Syra Health Corp.
SYRA
$0.097
-$0.001-1.02%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 14.07% | 33.04% | 44.73% | 35.47% | 25.18% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.07% | 33.04% | 44.73% | 35.47% | 25.18% |
| Cost of Revenue | 5.96% | 33.45% | 51.19% | 26.89% | 12.85% |
| Gross Profit | 38.04% | 31.86% | 25.91% | 71.04% | 85.05% |
| SG&A Expenses | -25.67% | -2.18% | 22.04% | 47.24% | 48.54% |
| Depreciation & Amortization | -16.64% | 14.92% | 28.22% | 45.49% | 43.57% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.15% | 12.92% | 39.80% | 45.93% | 37.77% |
| Operating Income | 64.76% | 21.45% | -30.38% | -69.83% | -66.15% |
| Income Before Tax | 65.18% | 22.64% | -27.94% | -66.30% | -63.83% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 65.18% | 22.64% | -27.94% | -66.30% | -63.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 65.18% | 22.64% | -27.94% | -66.30% | -63.83% |
| EBIT | 64.76% | 21.45% | -30.38% | -69.83% | -66.15% |
| EBITDA | 65.40% | 21.96% | -30.41% | -69.84% | -66.06% |
| EPS Basic | 76.91% | 44.03% | 9.83% | -30.31% | -33.75% |
| Normalized Basic EPS | 76.93% | 44.06% | 9.87% | -30.25% | -33.67% |
| EPS Diluted | 76.91% | 44.03% | 9.83% | -30.31% | -33.75% |
| Normalized Diluted EPS | 76.93% | 44.06% | 9.87% | -30.25% | -33.67% |
| Average Basic Shares Outstanding | 70.51% | 63.36% | 55.17% | 6.95% | -3.69% |
| Average Diluted Shares Outstanding | 70.51% | 63.36% | 55.17% | 6.95% | -3.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |